News
A senior scientist at the U.S. Centers for Disease Control and Prevention has resigned, warning that changes in leadership ...
A leading infectious disease expert and one of the nation’s foremost COVID-19 researchers has voiced deep concerns about the ...
The updated agenda for the Advisory Committee on Immunization Practices comes a week after Kennedy announced he had dismissed ...
It is the panel’s first meeting with Kennedy’s newly appointed members, many of whom are well-known vaccine critics.
The advisers to the Centers for Disease Control and Prevention will meet on June 25 and 26 to vote on who should receive shots for respiratory syncytial virus and influenza, according to a draft ...
(Reuters) -The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory ...
A CDC official who oversaw the agency’s Respiratory Virus Hospitalization Surveillance Network, known as RESP-NET, has resigned, citing concerns about how the data will be used to inform vaccine ...
3h
Zacks Investment Research on MSNGSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, ...
A few of the new members Health Secretary Robert F. Kennedy Jr. appointed to the federal vaccine panel have promoted ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results